Statistics
Publications
2
Citations
43
H-Index
2
Active since
2022
Affiliations
Hubei University of Chinese Medicine(Current)
Qi Rao is an author at Hubei University of Chinese Medicine specializing in oncology, vegf pathway inhibition, and angiogenesis in cancer.
Publications per year
2022–2023
2
2
Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP‐2/‐9
Qi Rao, Yu He, Ruochan Li et al. · Fundamental and Clinical Pharmacology · 2023 · 31 citations
Medicine, Oncology, Pharmacology +13
Qi Rao, Ruochan Li, Yu He et al. · Oncology Letters · 2022 · 12 citations · Full text
Medicine, Oncology, Pharmacology +16
1–2 of 2